DrugPatentWatch Database Preview

TRULANCE Drug Profile

« Back to Dashboard

Which patents cover Trulance, and what generic alternatives are available?

Trulance is a drug marketed by Synergy Pharms and is included in one NDA. There are eight patents protecting this drug.

This drug has fifty-two patent family members in fourteen countries.

The generic ingredient in TRULANCE is plecanatide. One supplier is listed for this compound. Additional details are available on the plecanatide profile page.

Summary for TRULANCE

International Patents:	52
US Patents:	8
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	2
Clinical Trials:	2
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for TRULANCE
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for TRULANCE
DailyMed Link:	TRULANCE at DailyMed

Generic Entry Opportunity Date for TRULANCE

NDA:

208745

Dosage:

TABLET;ORAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for TRULANCE

Drug Class	Guanylate Cyclase-C Agonist
Mechanism of Action	Guanylate Cyclase Activators

US Patents and Regulatory Information for TRULANCE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Synergy Pharms	TRULANCE	plecanatide	TABLET;ORAL	208745-001	Jan 19, 2017		RX	Yes	Yes				Y
Synergy Pharms	TRULANCE	plecanatide	TABLET;ORAL	208745-001	Jan 19, 2017		RX	Yes	Yes			Y
Synergy Pharms	TRULANCE	plecanatide	TABLET;ORAL	208745-001	Jan 19, 2017		RX	Yes	Yes
Synergy Pharms	TRULANCE	plecanatide	TABLET;ORAL	208745-001	Jan 19, 2017		RX	Yes	Yes
Synergy Pharms	TRULANCE	plecanatide	TABLET;ORAL	208745-001	Jan 19, 2017		RX	Yes	Yes				Y
Synergy Pharms	TRULANCE	plecanatide	TABLET;ORAL	208745-001	Jan 19, 2017		RX	Yes	Yes				Y

International Patents for TRULANCE

Country	Document Number	Estimated Expiration
Canada	2905585
Japan	2012149071
Hong Kong	1221959
Hong Kong	1204454
European Patent Office	2621509
Australia	2016216716